Bone marrow cellularity

2 papers1 finding

Animals2

Interventions

1

Rapamycin-preconditioned placenta-derived mesenchymal stem cells

upin mice1

1 study

Rapamycin-preconditioned placenta-derived mesenchymal stem cells improve bone marrow cellularity in mice.
“rPD-MSCs better enhance hematopoietic recovery, restore bone marrow cellularity, and increase peripheral blood cell counts by elevating the secretion of hematopoietic cytokines compared to non-preconditioned cells.”
Animalsin irradiated ICR/CD1 mice compared to non-preconditioned cellsbone marrow21 days
Preconditioning with Rapamycin Improves Therapeutic Potential of Placenta-Derived Mesenchymal Stem Cells in Mouse Model of Hematopoietic Acute Radiation Syndrome
International journal of molecular sciences17 May 2025

More on Rapamycin-preconditioned placenta-derived mesenchymal stem cells

Latest

1 in 12 months

The Journal of Clinical Investigation31 Mar

Deconstructing senescence phenotypes in cells of the bone and bone marrow

CommentaryCellular senescence

International Journal of Molecular Sciences28 May

Preconditioning with Rapamycin Improves Therapeutic Potential of Placenta-Derived Mesenchymal Stem Cells in Mouse Model of Hematopoietic Acute Radiation Syndrome

Experiments in miceRapamycin

Nature Communications11 May

Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells

Experiments in animalsNicotinamide riboside

Nature7 Jun

DNA repair is limiting for haematopoietic stem cells during ageing

Experiments in miceDNA repair

Mechanisms of Ageing and Development1 Mar

Comparison of haemopoiesis in young and old mice

Experiments in miceMechanisms